Smart Missiles vs Prostate Cancer: Why “Castration‑Resistant” No Longer Means Game Over. An Oncologist's Discovery

Send us Fan Mail In this episode, we rewrite one of the scariest phrases in men’s health: castration‑resistant prostate cancer. Instead of a dead end, it is now a signal to change strategy—not to give up. Drawing on landmark research from late 2024 and 2025, we unpack three new pillars of hope: PSMA‑targeted “smart missile” radioligand therapy like Pluvicto, precision genetic drugs that cut the cancer’s escape lines, and powerful immunotherapy combinations that can even help men with aggressi...